SHANIQUE THOMPSON: Open Payments
NPI 1609582980 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 168 payments from 13 companies in 2025. Trend: 2023 $44 · 2024 $1,520 · 2025 $2,371
Food & beverage: $2,262Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $526 |
| Neurocrine BioSciences, Inc. | 60 | $477 |
| ABBVIE INC. | 20 | $405 |
| Janssen Pharmaceuticals, Inc | 14 | $295 |
| Alkermes, Inc. | 11 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $158 |
| E.R. Squibb & Sons, L.L.C. | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: INGREZZA, VRAYLAR, INVEGA, UZEDY, ARISTADA, AUSTEDO XR, CAPLYTA, COBENFY.
Industry payments across FL — which companies pay providers there.
